Peritoneal dialysis: A primary care perspective

Journal of the American Board of Family Medicine

Volumn 19, Issue 4, 2006, Pages 380-389

  Saxena, Ramesh ^a   West, Cheryl ^b  

^a UNIVERSITY OF TEXAS AT DALLAS   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; AZITHROMYCIN; CEFADROXIL; CEFALEXIN; CEFAZOLIN; CLARITHROMYCIN; CLINDAMYCIN; CONTRAST MEDIUM; GENTAMICIN; GLUCOSE DEHYDROGENASE; ICODEXTRIN; NONSTEROID ANTIINFLAMMATORY AGENT; PERITONEAL DIALYSIS FLUID; PYRROLOQUINOLINEQUINONE; VANCOMYCIN;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ABNORMALLY LOW SUBSTRATE CONCENTRATION IN BLOOD; ALKALINE PHOSPHATASE BLOOD LEVEL; AMYLASE BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DRUG DOSE REGIMEN; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; HYPERGLYCEMIA; INTERMETHOD COMPARISON; KIDNEY FAILURE; KIDNEY FUNCTION; PANCREATITIS; PERITONEAL DIALYSIS; PERITONITIS; PRIMARY MEDICAL CARE; REVIEW; SURVIVAL; TREATMENT DURATION;

DIALYSIS SOLUTIONS; GLOMERULAR FILTRATION RATE; GLUCANS; GLUCOSE; HUMANS; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; PRIMARY HEALTH CARE;

EID: 33745910887     PISSN: 15572625     EISSN: 15587118     Source Type: Journal    
DOI: 10.3122/jabfm.19.4.380     Document Type: Review

References (51)

1. United States Renal Data System, Annual Data Report 2003, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
2. Coresh J, Wei GL, McQuillen G, et al. Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch Intern Med 2001;161:1207-16.
3. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Kidney disease outcome quality initiative. Am J Kidney Dis 2002;39:S1-246.
4. Nagy JA. Peritoneal morphology and function. Kidney Int 1996;50(Suppl 56):S2-11.
5. Rubin JL, Clawson M, Planch A, Jones Q. Measurements of peritoneal surface area in man and rat. Am J Med Sci 1988;295:435-8.
6. Gokal R, Alexander S, Ash S, et al. Peritoneal catheters and exit site practices toward optimum peritoneal access. 1998 update. Perit Dial Int 1998;18:11-33.
7. Waniewski J. Mathematical models for peritoneal transport characteristics. Perit Dial Int 1999;19:S193-201.
8. Rippe B, Stelin G, Haraldsson B. Computer simulations of peritoneal fluid transport in CAPD. Kidney Int 1991;40:315-25.
9. Twardowski ZJ, Nolph KD, Khanna R, et al. Peritoneal equilibration test. Perit Dial Bull 1987;7:138-47.
10. Kreidet RT, Lindholm B, Rippe B. Pathophysiology of peritoneal membrane failure. Perit Dial Int 2000;20(Suppl 4):S22-42.
11. United States Renal Data System, Annual Data Report 2004 (Economic costs of ESRD, Tables K16-K20), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
12. O'Seaghdha CM, Foley RN. Septicemia, access, cardiovascular disease and death in dialysis patients. Perit Dial Int 2005;25:534-40.
13. Chan TM, Lok AS, Cheng IK. Hepatitis C infection among dialysis patients: a comparison between patients on maintenance hemodialysis and continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 1991;6:944-7.
14. Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT. Predictor of rate of decline of residual renal function in incident dialysis patients. Kidney Int 2002;62:1046-53.
15. Bleyer AJ, Burkart JM, Russell GB, Adams PL. Dialysis modality and delayed graft function after cadaveric renal transplantation. J Am Soc Nephrol 1999;10:154-9.
16. Strippoli GFM, Tong A, Johnson D, Schena F, Craig JC. Catheter-related interventions to prevent peritonitis in peritoneal dialysis: a systemic review of randomized controlled trials. J Am Soc Nephrol 2004;15:2735-46.
17. Pirano B, Bailie GR, Bernardini J, et al. Peritoneal dialysis-related infections recommendations: 2005 update. Perit Dial Int 2005;25:107-31.
18. Dajani AS, Taubert KA, Wilson W, et al. Prevention of bacterial endocarditis. Recommendations by the American Heart Association. JAMA 1997;277:1794-801.
19. Bargman JM. Non-infectious complications of peritoneal dialysis. In: Gokal R, Khanna R, Krediet R, Nolph K, editors. Textbook of peritoneal dialysis, 2000, (2nd ed). Dordrecht, The Netherlands: Kluver Academic Publisher; 2000, p. 609-646.
20. Delarue J, Maingourd C, Lamisse F. Glucose oxidation after a peritoneal and an oral glucose load in a dialyzed patients. Kidney Int 1994;45:1147-52.
21. Wheeler DC. Abnormalities of lipoprotein metabolism in CAPD patients. Kidney Int 1996;54(Suppl 56):S41-6.
22. Quellhorst E. Insulin therapy during peritoneal dialysis: Pros and cons of various forms of administration. J Am Soc Nephrol 2002;13:592-6.
23. Bargman JM, Thorpe KE, Churchill DN. Relative contribution of residual renal function and peritoneal clearance of adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 2001;12:2158-62.
24. Paniagua R, Amato D, Vonesh E, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective randomized controlled trial. J Am Soc Nephrol 2002;13:1307-20.
25. Singhal MK, Bhaskaran S, Vidgne E. Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it. Perit Dial Int 2000;20:429-38.
26. Li PK-T, Chow K-M, Wong TY-H, Leung C-B, Szeto C-C. Effects of an angiotensin-converting enzyme inhibitor on residual renal function in patients receiving peritoneal dialysis. A randomized controlled study. Ann Intern Med 2003;139:105-12.
27. Collins AJ, Hao W, Xia H, et al. Mortality risks of peritoneal dialysis and hemodialysis. Am J Kid Dis 1999;34:1065-74.
28. Fenton SSA, Schaubel DE, Desmeules M, et al. Hemodialysis versus peritoneal dialysis: a comparison of adjusted mortality rates. Am J Kid Dis 1997;30:334-42.
29. Korevaar JC, Feith GW, Dekker FW, et al. Effect of starting with hemodialysis compared with peritoneal dialysis in patients new on dialysis treatment: a randomized controlled trial. Kidney Int 2003;64:2222-8.
30. Vonesh EF, Snyder JJ, Foley RN, Collins AJ. The differential impact of risk factors on mortality in hemodialysis and peritoneal dialysis. Kidney Int 2004;66:2389-401.
31. Termorshuizen F, Korevaar JC, Dekker FW, Van Manen JG, Boeschoten EW, Krediet RT. Hemodialysis and peritoneal dialysis: comparison of adjusted mortality rates according to the duration of dialysis: analysis of the Netherlands cooperative study on adequacy of dialysis 2. J Am Soc Nephrol 2003;14: 2851-60.
32. Jaar BG, Coresh J, Plantings IC, et al. Comparing the risk for death with peritoneal dialysis and hemodialysis in a national cohort of patients with chronic kidney disease. Ann Intern Med 2005;143:174-83.
33. Ganesh SK, Hulbert-Shearon T, Port FK, Eagle K, Stack AG. Mortality differences by dialysis modality among incident ESRD patients with and without coronary artery disease. J Am Soc Nephrol 2003;14:415-24.
34. Stack AG, Molony DA, Rahman NS, Dosekun A, Murthy B. Impact of dialysis modality on survival of new ESRD patients with congestive heart failure in the United States. Kidney Int 2003;64:1071-9.
35. Rubin HR, Fink NE, Plantinga LC, Sadler JH, Kliger AS, Powe NR. Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis. JAMA 2004;291:697-703.
36. Stack AG. Determinants of modality selection among incident dialysis patients: Results from a national study. J Am Soc Nephrol 2002;13:1279-87.
37. Mehrotra R, Blake P, Berman N, Nolph KD. An analysis of dialysis training in the United States and Canada. Am J Kidney Dis 2002;40:152- 60.
38. Kinchen KS, Sadler J, Fink N, Brookmeyer R, Klag MJ, Levey AS, Powe NR. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med 2002;137:479-86.
39. Stack AG. Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States. Am J Kidney Dis 2003;41:310-8.
40. Golper T. Patient education: can it maximize the success of therapy? Nephrol Dial Transplant 2001;16(Suppl 7):20-4.
41. Davies S, Phillips L, Griffiths AM, Russell LH, Naish PF, Russell GI. What really happens to people on long-term peritoneal dialysis? Kidney Int 1998;54:2207-17.
42. Kawaguchi Y, Hasegawa T, Nakayama M, Kubo H, Shigematu T. Issues affecting the longevity of continuous ambulatory peritoneal dialysis. Kidney Int 1997;52(Suppl 62):S105-7.
43. Williams JD, Craig KJ, Ruhland CV, Topley N, Williams GT. The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int 2003;64(Suppl 88):S43-9.
44. Wolfson M, Piraino B, Hamburger RJ, Morton R. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis. Am J Kidney Dis 2002;40:1055-65.
45. Wolfson M, Ogrinc F, Mujais S. Review of clinical trial experience with icodextrin. Kidney Int 2002;62(Suppl 81):S46-52.
46. Lopez EG, Lindholm B, Tranaeus A. Biocompatibility of new peritoneal dialysis solutions: clinical experience. Perit Dial Int 2000;20(Suppl 5):S48-56.
47. Mortier S, Faict D, Schalkwijk CG, Lameire NH, Vriese ASD. Long-term exposure to new peritoneal dialysis solutions: effects on the peritoneal membrane. Kidney Int 2004;66:1257-65.
48. Williams JD, Topley N, Craig KJ, et al. The Euro-Balance trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on peritoneal membrane. Kidney Int 2004;66:408-18.
49. Wens R, Taminne M, Devriendt J, et al. A previously undescribed side effect of icodextrin: Overestimation of glycemia by glucose analyzer. Perit Dial Int 1998;18:603-9.
50. Grzegorzewska AE, Antczak-Jedrzejczak D, Mariak I. Polyglucose dialysis solution influences serum activity of amylase and lipase differentially. Adv Perit Dial 2000;16:113-8.
51. Plum J, Gentile S, Verger C, et al. Efficacy and safety of a 7.5% icodextrin peritoneal dialysis solution in patients treated with automated peritoneal dialysis. Am J Kidney Dis 2002;39:862-71.